| dc.contributor.author | Safaei, S | |
| dc.contributor.author | Baradaran, B | |
| dc.contributor.author | Hagh, MF | |
| dc.contributor.author | Alivand, MR | |
| dc.contributor.author | Talebi, M | |
| dc.contributor.author | Gharibi, T | |
| dc.contributor.author | Solali, S | |
| dc.date.accessioned | 2018-08-26T08:51:15Z | |
| dc.date.available | 2018-08-26T08:51:15Z | |
| dc.date.issued | 2018 | |
| dc.identifier.uri | http://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/53313 | |
| dc.description.abstract | The authors regret and would like to bring to your kind notice that a mistake occurred during paper (Double sword role of EZH2 in leukemia) submission, we would be tremendously grateful if you replaced the sent figure (placed below) with the previously attached one (Fig. 1 one of article). [Figure presented] The authors would like to apologise for any inconvenience caused. é 2018 | |
| dc.language.iso | English | |
| dc.relation.ispartof | Biomedicine and Pharmacotherapy | |
| dc.subject | Erratum | |
| dc.subject | error | |
| dc.title | Corrigendum to "double sword role of EZH2 in leukemia" [Biomed. Pharmacother. 98 (2018) 626-635](S0753332217353878)(10.1016/j.biopha.2017.12.059) | |
| dc.type | Article | |
| dc.citation.volume | 101 | |
| dc.citation.spage | 786 | |
| dc.citation.index | Scopus | |
| dc.identifier.DOI | https://doi.org/10.1016/j.biopha.2018.02.101 | |
